The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform
The goal is to better support drug developers as programs move from laboratory research into clinical trials
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
Move amid evidence of widespread reporting gaps
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
Scientists at the forum warned of an increasingly volatile health landscape
Subscribe To Our Newsletter & Stay Updated
